PHRRF (PharmaTher Holdings) Debt-to-Equity : 0.00 (As of Aug. 2024)

PharmaTher Holdings Debt-to-Equity Chart

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24
Debt-to-Equity	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of PharmaTher Holdings's Debt-to-Equity

For the Biotechnology subindustry, PharmaTher Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaTher Holdings's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Debt-to-Equity falls into.

PharmaTher Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

PharmaTher Holdings's Debt to Equity Ratio for the fiscal year that ended in May. 2023 is calculated as

PharmaTher Holdings's Debt to Equity Ratio for the quarter that ended in Aug. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings  (OTCPK:PHRRF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

PharmaTher Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings Business Description